Care Transformation Center Blog

Find the right intervention for high- and rising-risk patients

by Megan Clark

One of our most popular posts this summer was on the three types of patients central to population health success—and why high-, rising-, and low-risk patients require different goals, resources, and care models.

But when it comes to preventive interventions for each patient group, how do you target the right one, particularly for high- and rising-risk patients, who have multiple comorbidities?



Insights from Crimson Labs

My colleague Brett Erhardt, over at Crimson Labs, recently highlighted two ways to match the right patient to the right intervention.

For high-risk patients, it's especially important to prioritize the condition that needs to be addressed first. For example, if you identify every patient with congestive heart failure, you are likely to include patients that have CHF and another condition, ranging from diabetes to cancer to severe dementia. If you have a care management initiative aimed at reducing CHF admissions, you'll have to decide if any of these conditions need to be addressed before you can focus on CHF.

For rising-risk patients, the clinical risk drivers can offer a quantitative look at how each disease and medical condition could affect a patient's future risk score. By evaluating these risk factors, staff can identify those patients that will most likely benefit from care management.

To learn more about these findings and view examples from the Crimson cohort, check out Crimson Labs'  recent blog post.

About Crimson Labs

Every day, the Crimson performance technology platform analyzes millions of clinical and financial data from over a thousand hospitals and physician practices. Crimson Labs is a new Advisory Board blog that highlights our findings and provides tangible action steps for organizations to improve quality and reduce costs.

FOLLOW THE BLOG

Suggested Reading

  • How Texas Health Resources is creating 'a science out of well-being'

    Texas Health Resources is partnering with a well-being solutions company to develop a risk stratification system that incorporates a comprehensive well-being assessment with traditional biometric data. We recently sat down with THR's chief strategy officer to learn more about the organization's approach.

Follow our new blog, Crimson Labs, to see more of what we’re learning from the millions of pieces of clinical and financial data analyzed daily by the Crimson performance technology platform.


 

Recent Posts from The Care Transformation Center Blog

Our top resources on strengthening hospital-physician alignment

Three steps for adopting a contracts-driven CI strategy

Time to 'face the facts' on building the evidence-based organization

Where do advanced practitioners fit in the care team?


 

See More Posts on Risk Stratification

How Texas Health Resources is creating 'a science out of well-being'

Beyond clinical risk: Next-generation high-risk patient identification tools

Risk stratification methods to reduce heart failure readmissions

Liverpool Lung Project: A new way to personalize cancer risk


 

Interested in Membership?

Learn more about the Crimson performance technology platform and how we can help your organization. Contact us.


 

Meet the Author

Megan Clark
Practice Manager
Health Care Advisory Board